Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

BACKGROUND: Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for patients without a fully human leukocyte antigen (HLA)-matched donor. Here, we compared the allo-HCT outcomes of CBT versus s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dholaria, Bhagirathbhai, Labopin, Myriam, Sanz, Jaime, Ruggeri, Annalisa, Cornelissen, Jan, Labussière-Wallet, Hélène, Blaise, Didier, Forcade, Edouard, Chevallier, Patrice, Grassi, Anna, Zubarovskaya, Ludmila, Kuball, Jürgen, Ceballos, Patrice, Ciceri, Fabio, Baron, Frederic, Savani, Bipin N., Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094558/
https://www.ncbi.nlm.nih.gov/pubmed/33941226
http://dx.doi.org/10.1186/s13045-021-01086-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094558/
https://www.ncbi.nlm.nih.gov/pubmed/33941226
http://dx.doi.org/10.1186/s13045-021-01086-2

Ejemplares similares